ArticleCancers2024

The Combination of Anti-CD47 Antibody with CTLA4 Blockade Enhances Anti-Tumor Immunity in Non-Small Cell Lung Cancer via Normalization of Tumor Vasculature and Reprogramming of the Immune Microenvironment.

Zhan Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.